MX346361B - Nanoparticulas que comprenden esteres de poli(metil vinil eter-co-anhidrido maleico) y los usos de las mismas. - Google Patents
Nanoparticulas que comprenden esteres de poli(metil vinil eter-co-anhidrido maleico) y los usos de las mismas.Info
- Publication number
- MX346361B MX346361B MX2013011959A MX2013011959A MX346361B MX 346361 B MX346361 B MX 346361B MX 2013011959 A MX2013011959 A MX 2013011959A MX 2013011959 A MX2013011959 A MX 2013011959A MX 346361 B MX346361 B MX 346361B
- Authority
- MX
- Mexico
- Prior art keywords
- nanoparticles
- poly
- maleic anhydride
- vinyl ether
- methyl vinyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8164—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F265/00—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
- C08F265/04—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of esters
- C08F265/06—Polymerisation of acrylate or methacrylate esters on to polymers thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/07—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media from polymer solutions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/126—Polymer particles coated by polymer, e.g. core shell structures
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/14—Powdering or granulating by precipitation from solutions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- C08L33/04—Homopolymers or copolymers of esters
- C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
- C08L33/062—Copolymers with monomers not covered by C08L33/06
- C08L33/064—Copolymers with monomers not covered by C08L33/06 containing anhydride, COOH or COOM groups, with M being metal or onium-cation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2329/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Derivatives of such polymer
- C08J2329/10—Homopolymers or copolymers of unsaturated ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2335/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Derivatives of such polymers
- C08J2335/08—Copolymers with vinyl ethers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Dermatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a nanopartículas para encapsular compuestos, la preparación y los usos de las mismas, basándose dichas nanopartículas en semiésteres de alquilo (C1-C4) de copolímeros de poli (metil vinil éter y anhídrido maleico) (PVM/MA). Dichas nanopartículas pueden encapsular o incorporar un producto de interés para su uso en los sectores agrícola, cosmético, alimentario o farmacéutico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11382115A EP2510930A1 (en) | 2011-04-15 | 2011-04-15 | Nanoparticles comprising half esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof |
PCT/EP2012/056900 WO2012140252A1 (en) | 2011-04-15 | 2012-04-16 | Nanoparticles comprising esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013011959A MX2013011959A (es) | 2014-08-29 |
MX346361B true MX346361B (es) | 2017-03-15 |
Family
ID=44537577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013011959A MX346361B (es) | 2011-04-15 | 2012-04-16 | Nanoparticulas que comprenden esteres de poli(metil vinil eter-co-anhidrido maleico) y los usos de las mismas. |
Country Status (11)
Country | Link |
---|---|
US (1) | US9351940B2 (es) |
EP (2) | EP2510930A1 (es) |
JP (1) | JP6001640B2 (es) |
CN (1) | CN103619918A (es) |
AR (1) | AR087149A1 (es) |
AU (1) | AU2012241758B2 (es) |
CA (1) | CA2833188A1 (es) |
ES (1) | ES2730119T3 (es) |
MX (1) | MX346361B (es) |
PT (1) | PT2699625T (es) |
WO (1) | WO2012140252A1 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9878000B2 (en) | 2012-06-20 | 2018-01-30 | University Of Waterloo | Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof |
US20140005379A1 (en) | 2012-06-20 | 2014-01-02 | Frank GU | Nanoparticle delivery system and components thereof |
GB2528404A (en) * | 2013-03-11 | 2016-01-20 | Univ North Carolina State | Functionalized environmentally benign nanoparticles |
KR20240011239A (ko) | 2014-10-29 | 2024-01-25 | 삼손 클리니컬 피티와이 엘티디 | 과도한 모발 쉐딩의 검출 및 치료 |
WO2016071365A1 (en) * | 2014-11-03 | 2016-05-12 | Spherium Biomed, S.L. | Topical pharmaceutical compositions of paclitaxel |
PL3233126T3 (pl) * | 2014-12-01 | 2019-09-30 | Innoup Farma, S.L. | Nanocząstki do enkapsulacji związków, ich przygotowanie i zastosowania |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
CN105343031B (zh) * | 2015-11-24 | 2018-06-15 | 南京农业大学 | 一种伊维菌素固体脂质纳米粒及其制备方法 |
RU2618449C1 (ru) * | 2016-01-12 | 2017-05-03 | Александр Александрович Кролевец | Способ получения нанокапсул витаминов группы В в каппа-каррагинане |
CN107028894B (zh) * | 2016-02-03 | 2020-11-06 | 三捷生物科技(北京)有限公司 | 一种载药微球及其制备方法和应用 |
US10039801B2 (en) | 2016-02-16 | 2018-08-07 | Strongbridge Ireland Limited | Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use |
US20190071521A1 (en) * | 2016-03-03 | 2019-03-07 | Boai Nky Medical Holdings Ltd. | Fine and Uniform Methyl Vinyl Ether-Maleic Acid Inorganic Salt Copolymers and Their Use in Oral Care and Pharmaceutical Applications |
EP3222270A1 (en) | 2016-03-23 | 2017-09-27 | Bionanoplus, S.L. | Compositions for mucosal adhesion and uses thereof |
CN106035397A (zh) * | 2016-06-20 | 2016-10-26 | 河南中天恒信生物化学科技有限公司 | 一种生物除草剂及其制备方法 |
RU2646474C1 (ru) * | 2016-09-13 | 2018-03-05 | Александр Александрович Кролевец | Способ получения нанокапсул витаминов группы В |
WO2019002362A1 (en) * | 2017-06-28 | 2019-01-03 | Spherium Biomed, S.L. | TOPICAL COMPOSITIONS OF CYCLOSPORIN A |
US20190269684A1 (en) * | 2017-07-12 | 2019-09-05 | Samson Clinical Pty Ltd | Promoting hair growth and treatment of hair loss or excessive hair shedding |
KR101947315B1 (ko) * | 2018-05-10 | 2019-02-12 | 서울과학기술대학교 산학협력단 | 티로졸을 함유하는 폴리옥살레이트 나노입자 |
JP7323608B2 (ja) * | 2018-10-11 | 2023-08-08 | アリヴィオ セラピューティクス, インコーポレイテッド | スマート放出のための非注射用ヒドロゲル製剤 |
WO2021064608A1 (en) * | 2019-09-30 | 2021-04-08 | Centitvc - Centro De Nanotecnologia E Materiais Técnicos Funcionais E Inteligentes | Capsule for functionalizing a product, method and uses thereof |
CN111138786B (zh) * | 2020-01-13 | 2022-07-12 | 上海应用技术大学 | 一种壳聚糖plga纳米香精的制备方法与应用 |
CN111617092A (zh) * | 2020-04-20 | 2020-09-04 | 牡丹江医学院 | 一种用于治疗肺癌的药物及其制备方法 |
CN111777775B (zh) * | 2020-07-01 | 2023-03-31 | 宁波艾捷康宁生物科技有限公司 | 一种酰胺型交联聚合物及其制备方法和其在生物蛋白质沉淀中的用途 |
EP4008184A1 (en) * | 2020-12-04 | 2022-06-08 | The Procter & Gamble Company | Antimicrobial composition comprising maleic acid/vinyl ether copolymer |
US11285148B1 (en) | 2021-07-23 | 2022-03-29 | King Abdulaziz University | Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles |
CN114053229B (zh) * | 2022-01-17 | 2022-04-22 | 山东国邦药业有限公司 | 一种盐酸沙拉沙星水溶性颗粒剂及其制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3382247A (en) | 1965-11-01 | 1968-05-07 | Upjohn Co | 6-amino-1, 2-dihydro-1-hydroxy-2-imino-4-phenoxypyrimidines |
FR1583243A (es) | 1968-08-05 | 1969-10-24 | ||
US4139619A (en) | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
US4596812A (en) | 1976-05-24 | 1986-06-24 | The Upjohn Company | Methods and solutions for treating male pattern alopecia |
US4164562A (en) * | 1977-10-21 | 1979-08-14 | American Cyanamid Company | Aerosol hair spray containing an ethyl or butyl monoester of a copolymer of maleic acid and a vinyl monomer |
LU83349A1 (fr) | 1981-05-08 | 1983-03-24 | Oreal | Composition sous forme de mousse aerosol a base de polymere cationique et de polymere anionique |
AU629316B2 (en) | 1990-04-11 | 1992-10-01 | Flora Inc. | Periodontal disease treatment system |
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
DE4327063A1 (de) | 1993-08-12 | 1995-02-16 | Kirsten Dr Westesen | Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften |
FR2732595A1 (fr) | 1995-04-07 | 1996-10-11 | Oreal | Utilisation de polymeres pour reduire l'effet irritant des actifs dans une composition cosmetique et/ou dermatologique |
CA2263765C (en) | 1996-08-19 | 2010-03-30 | Vivorx Pharmaceuticals, Inc. | Methods for the production of protein particles useful for delivery of pharmacological agents |
WO1999000013A2 (en) | 1997-06-30 | 1999-01-07 | Monsanto Company | Microparticles containing agricultural active ingredients |
US6149898A (en) * | 1998-06-22 | 2000-11-21 | The Procter & Gamble Company | Hair styling compositions containing silicone microemulsions and cationic non-polymeric liquids |
FR2787729B1 (fr) * | 1998-12-29 | 2001-01-26 | Oreal | Nanocapsules a base de polymeres anioniques hydrodispersibles, leur procede de preparation et compositions cosmetiques ou dermatologiques les contenant |
US20050037374A1 (en) * | 1999-11-08 | 2005-02-17 | Melker Richard J. | Combined nanotechnology and sensor technologies for simultaneous diagnosis and treatment |
AU4473101A (en) | 2000-04-07 | 2001-10-23 | Taisho Pharmaceutical Co Ltd | Hair growth stimulant compositions |
US7442369B1 (en) | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
ES2178961B1 (es) * | 2001-03-06 | 2004-07-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Fabricacion de nanoparticulas a base del copolimero de metil vinil eter y anhidrido maleico para la administracion de farmacos de naturaleza hidrofilica, en particular de bases puricas y pirimidinicas. |
WO2005016294A1 (en) * | 2003-08-07 | 2005-02-24 | The Procter & Gamble Company | Emulsions with a concentrated internal oil phase |
US7834210B2 (en) * | 2006-08-04 | 2010-11-16 | Bioderm Research | Hair loss prevention by natural amino acid and peptide complexes |
ES2246694B1 (es) | 2004-04-29 | 2007-05-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Nanoparticulas pegiladas. |
ES2246695B1 (es) * | 2004-04-29 | 2007-05-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico. |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
DE202004012607U1 (de) * | 2004-08-12 | 2004-11-04 | Wella Ag | Haarbehandlungsmittel mit Gehalt an fluoreszierenden Nanokompositpartikeln |
JP2008537940A (ja) | 2005-03-29 | 2008-10-02 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | 新しい毛包の形成、はげ頭症の治療、及び除毛をするための方法 |
WO2006119960A1 (en) * | 2005-05-06 | 2006-11-16 | Unilever Plc | Cosmetic composition comprising a micellar, shell cross-linked copolymer |
JP2009519940A (ja) | 2005-12-14 | 2009-05-21 | ザーズ, インコーポレイテッド | 皮膚科学的状態を処置するための組成物および方法 |
ES2286951B1 (es) | 2006-05-26 | 2008-10-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A | Nanoparticulas bioadhesivas para la administracion de moleculas biologicamente activas. |
ES2310122B1 (es) | 2007-04-20 | 2009-10-30 | Instituto Cientifico Y Tecnologico De Navarra, S.A | Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones. |
ES2358493B1 (es) | 2008-04-05 | 2012-06-13 | Instituto Cientifico Y Tecnologico De Navarra, S.A | Nanopartículas pegiladas que comprenden una molécula biológicamente activa y sus aplicaciones. |
WO2010008582A2 (en) | 2008-07-18 | 2010-01-21 | Rxi Pharmaceuticals Corporation | Phagocytic cell drug delivery system |
EP2672956A1 (en) | 2011-02-10 | 2013-12-18 | Moberg Pharma AB | Novel formulations for dermal, transdermal and mucosal use 1 |
-
2011
- 2011-04-15 EP EP11382115A patent/EP2510930A1/en not_active Withdrawn
-
2012
- 2012-04-16 JP JP2014504354A patent/JP6001640B2/ja active Active
- 2012-04-16 MX MX2013011959A patent/MX346361B/es active IP Right Grant
- 2012-04-16 AR ARP120101305A patent/AR087149A1/es unknown
- 2012-04-16 ES ES12715953T patent/ES2730119T3/es active Active
- 2012-04-16 US US14/111,855 patent/US9351940B2/en active Active
- 2012-04-16 CA CA2833188A patent/CA2833188A1/en not_active Abandoned
- 2012-04-16 WO PCT/EP2012/056900 patent/WO2012140252A1/en active Application Filing
- 2012-04-16 AU AU2012241758A patent/AU2012241758B2/en not_active Ceased
- 2012-04-16 PT PT12715953T patent/PT2699625T/pt unknown
- 2012-04-16 CN CN201280024452.2A patent/CN103619918A/zh active Pending
- 2012-04-16 EP EP12715953.1A patent/EP2699625B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20140161892A1 (en) | 2014-06-12 |
EP2699625B1 (en) | 2019-03-20 |
CA2833188A1 (en) | 2012-10-18 |
MX2013011959A (es) | 2014-08-29 |
AU2012241758B2 (en) | 2016-05-19 |
AU2012241758A1 (en) | 2013-11-14 |
CN103619918A (zh) | 2014-03-05 |
JP6001640B2 (ja) | 2016-10-05 |
WO2012140252A1 (en) | 2012-10-18 |
AR087149A1 (es) | 2014-02-26 |
ES2730119T3 (es) | 2019-11-08 |
PT2699625T (pt) | 2019-06-24 |
EP2510930A1 (en) | 2012-10-17 |
JP2014513082A (ja) | 2014-05-29 |
US9351940B2 (en) | 2016-05-31 |
EP2699625A1 (en) | 2014-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX346361B (es) | Nanoparticulas que comprenden esteres de poli(metil vinil eter-co-anhidrido maleico) y los usos de las mismas. | |
HK1209599A1 (en) | Products including capsules, uses and preparation thereof | |
HK1207978A1 (en) | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc | |
IL233200A0 (en) | The history of alpha-boronic acid, its preparation and pharmaceutical preparations containing it | |
MX353216B (es) | Productos antitranspirantes con proteinas y sales antitranspirantes. | |
SG11201406141UA (en) | Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient | |
PL3412676T3 (pl) | Cykliczne pochodne estrowe kwasu boronowego, sposób otrzymywania oraz ich zastosowania terapeutyczne | |
WO2012104275A3 (en) | Nanoparticles delivery systems, preparation and uses thereof | |
EA201590161A1 (ru) | Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона | |
EP3109309A3 (en) | Perfume systems | |
EP2578596A4 (en) | LEVOCARRIMYCIN, ITS PHARMACEUTICAL COMPOSITIONS, PREPARATION METHODS AND USES THEREOF | |
ZA201409367B (en) | A method to produce a medicinal product comprising a biologically active protein and the resulting product | |
IN2014DN10037A (es) | ||
ZA201504217B (en) | Strain of bifidobacterium animalis ssp. animalis | |
PL2562172T3 (pl) | Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania | |
EP3808378A8 (en) | Therapeutic proteins with increased half-life and methods of preparing same | |
GB2492037A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
BR112015003917A2 (pt) | composição de poliolefina, método de preparo de uma composição de poliolefina, produto de consumo e filme agrícola | |
MX2014012164A (es) | Composiciones a base de probioticos y un complejo de polen de abejas/arcilla, su preparacion y sus usos en nutricion y en terapeutica. | |
MX341642B (es) | Composicion de liberacion sostenida que contiene peptidos como ingredientes activos. | |
WO2011107866A3 (en) | Silyl-derivatives of polysaccharides | |
EP2551266A4 (en) | NON-NUCLEOSIDE 2 ', 2-DITHIAZOLE COMPOUNDS, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USES AS HEPATITIS VIRUS INHIBITORS | |
IT1401685B1 (it) | Procedimento e sistema per raggruppare prodotti da imballare. | |
IT1399398B1 (it) | Composizione farmaceutica a base di glicirrizina e polimero eg56 per la preparazione di prodotti ad azione flogolitica. | |
HK1203061A1 (en) | 1,3-diphenylpropane derivatives, preparations and uses thereof 13- |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |